Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,298 papers from all fields of science
Search
Sign In
Create Free Account
Polyvalent pneumococcal vaccine
Known as:
PPSV
, Pneumococcal Polysaccharide Vaccine [Chemical/Ingredient]
, Pneumococcal Polyvalent Vaccine
Expand
An polyvalent vaccine used to prevent infection by the bacterium Streptococcus pneumoniae. Pneumococcal polyvalent vaccine contains highly purified…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
23-valent pneumococcal capsular polysaccharide vaccine
Communicable Diseases
Drug Allergy
Hodgkin Disease
Expand
Broader (1)
Pneumococcal vaccine
Narrower (1)
Pneumovax 23
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1998
Highly Cited
1998
Predictors of occult pneumococcal bacteremia in young febrile children.
N. Kuppermann
,
G. Fleisher
,
D. Jaffe
Annals of Emergency Medicine
1998
Corpus ID: 23754095
Review
1992
Review
1992
Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae.
Graham J. Boulnois
Journal of General Microbiology
1992
Corpus ID: 41918578
Streptococcus pneumoniae is an important agent of disease in man at the extremes of age and in individuals with underlying…
Expand
Highly Cited
1989
Highly Cited
1989
Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components
I. Riesenfeld-Orn
,
S. Wolpe
,
Jose F. Garcia-Bustos
,
M. Hoffmann
,
Elaine Tuomanen
Infection and Immunity
1989
Corpus ID: 28549557
While there is considerable evidence that both interleukin-1 (IL-1) and tumor necrosis factor (TNF) are central mediators of…
Expand
Highly Cited
1988
Highly Cited
1988
Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal…
C. Lue
,
A. Tarkowski
,
J. Mestecky
Journal of Immunology
1988
Corpus ID: 41350122
Ig class-, and IgA and IgG subclass-specific immune responses to a 23 valent pneumococcal polysaccharide vaccine were studied at…
Expand
Highly Cited
1987
Highly Cited
1987
Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin.
M. Santosham
,
R. Reid
,
+7 authors
S. Foster
New England Journal of Medicine
1987
Corpus ID: 26603840
Apache Indian infants have a high frequency of Haemophilus influenzae type b (Hib) and pneumococcal infections. Forty percent of…
Expand
Highly Cited
1982
Highly Cited
1982
Pneumococcal disease in a medium-sized community in the United States.
M. Mufson
,
G. Oley
,
D. Hughey
Journal of the American Medical Association (JAMA…
1982
Corpus ID: 19887247
To assess the importance of bacteremic pneumococcal disease among the population of one "average" American community, we studied…
Expand
Highly Cited
1977
Highly Cited
1977
Immune function in aged mice. II. B-cell function.
R. Callard
,
A. Basten
,
L. Waters
Cellular Immunology
1977
Corpus ID: 35340491
Highly Cited
1972
Highly Cited
1972
Inhibition of secondary anti‐hapten responses with the hapten conjugated to type 3 pneumococcal polysaccharide
G. Mitchell
,
J. Humphrey
,
A. Williamson
,
Eur. J. Immunol. 1972
,
J. Kapp
European Journal of Immunology
1972
Corpus ID: 32295229
An injection of 2, 4‐dinitrophenyl (DNP)‐lysine conjugated to type 3 pneumococcal polysaccharide (DNP‐lysine‐SIII) markedly…
Expand
Highly Cited
1971
Highly Cited
1971
Studies on immunological paralysis: VI. Thymic-independence of tolerance and immunity to type III pneumococcal polysaccharide
J. Howard
,
G. Christie
,
B. Courtenay
,
E. Leuchars
,
A. Davies
1971
Corpus ID: 12873119
Highly Cited
1970
Highly Cited
1970
Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum.
P. Baker
,
R. Barth
,
P. Stashak
,
D. F. Amsbaugh
Journal of Immunology
1970
Corpus ID: 44371877
Mice treated with antilymphocyte serum (ALS) and immunized with type III pneumococcal polysaccharide (SSS-III) showed a tenfold…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE